{"id":"il-yang-flu-vaccine-pre-filled-syringe","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain, redness, or swelling"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an inactivated influenza vaccine in pre-filled syringe format, it contains viral antigens that trigger both humoral (antibody) and cell-mediated immune responses. This prepares the immune system to recognize and neutralize circulating influenza viruses, reducing infection risk and disease severity in vaccinated individuals.","oneSentence":"IL-YANG Flu Vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains included in the vaccine formulation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:15:32.579Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and/or pediatric populations"}]},"trialDetails":[{"nctId":"NCT04381689","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2024-10-23","conditions":"Healthy","enrollment":245},{"nctId":"NCT02263131","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Children","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2013-10","conditions":"Healthy","enrollment":416},{"nctId":"NCT03445468","phase":"PHASE3","title":"Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2017-09-20","conditions":"Influenza, Human","enrollment":379}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"IL-YANG Flu Vaccine Pre-filled Syringe","genericName":"IL-YANG Flu Vaccine Pre-filled Syringe","companyName":"Il-Yang Pharm. Co., Ltd.","companyId":"il-yang-pharm-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"IL-YANG Flu Vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains included in the vaccine formulation. Used for Seasonal influenza prevention in adults and/or pediatric populations.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}